IL109234A - Indole derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Indole derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL109234A
IL109234A IL109234A IL10923494A IL109234A IL 109234 A IL109234 A IL 109234A IL 109234 A IL109234 A IL 109234A IL 10923494 A IL10923494 A IL 10923494A IL 109234 A IL109234 A IL 109234A
Authority
IL
Israel
Prior art keywords
compound
indole
methoxy
formula
pyridin
Prior art date
Application number
IL109234A
Other languages
English (en)
Other versions
IL109234A0 (en
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of IL109234A0 publication Critical patent/IL109234A0/xx
Publication of IL109234A publication Critical patent/IL109234A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
IL109234A 1993-04-08 1994-04-06 Indole derivatives, their preparation and pharmaceutical compositions containing them IL109234A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale

Publications (2)

Publication Number Publication Date
IL109234A0 IL109234A0 (en) 1994-07-31
IL109234A true IL109234A (en) 1998-04-05

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
IL109234A IL109234A (en) 1993-04-08 1994-04-06 Indole derivatives, their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US5834493A (cs)
EP (1) EP0694033A1 (cs)
JP (1) JPH08508738A (cs)
CN (1) CN1124960A (cs)
AU (1) AU684276B2 (cs)
BG (1) BG100040A (cs)
BR (1) BR9406206A (cs)
CA (1) CA2160020A1 (cs)
CZ (1) CZ283398B6 (cs)
FI (1) FI954734L (cs)
HU (1) HUT74090A (cs)
IL (1) IL109234A (cs)
IT (1) IT1271352B (cs)
NO (1) NO953967L (cs)
NZ (1) NZ265055A (cs)
PL (1) PL310995A1 (cs)
SG (1) SG50507A1 (cs)
SK (1) SK119795A3 (cs)
WO (1) WO1994024125A1 (cs)
ZA (1) ZA942383B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
WO1998051685A1 (en) * 1997-05-09 1998-11-19 H. Lundbeck A/S Method of manufacturing sertindole
JP2002509149A (ja) 1998-01-14 2002-03-26 ザ ユーエイビー リサーチ ファウンデイション 細菌nadシンテターゼ酵素の阻害剤の合成およびスクリーニング方法、その化合物、ならびに細菌nadシンテターゼ酵素の阻害剤を用いる細菌および微生物感染の治療方法
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
JP2002510676A (ja) * 1998-04-08 2002-04-09 アメリカン・ホーム・プロダクツ・コーポレイション うつ病治療用のn−アリールオキシエチルアミン誘導体
JP2002513018A (ja) * 1998-04-29 2002-05-08 アメリカン・ホーム・プロダクツ・コーポレイション セロトニン作動薬
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MXPA03005433A (es) 2000-12-22 2003-09-10 Wyeth Corp Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
KR101868165B1 (ko) * 2010-04-22 2018-07-19 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
WO2013155504A1 (en) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc. Novel methods
WO2014145192A1 (en) 2013-03-15 2014-09-18 Intra-Cellular Therapies, Inc. Organic compounds
CN105939712A (zh) 2013-12-03 2016-09-14 细胞内治疗公司 新方法
US9745300B2 (en) 2014-04-04 2017-08-29 Intra-Cellular Therapies, Inc. Organic compounds
KR20170012210A (ko) 2014-04-04 2017-02-02 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
EP3331530A4 (en) * 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
KR20240170975A (ko) 2016-01-26 2024-12-05 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
ES2879888T3 (es) 2016-03-25 2021-11-23 Intra Cellular Therapies Inc Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central
EP3436083A4 (en) 2016-03-28 2019-11-27 Intra-Cellular Therapies, Inc. NOVEL COMPOSITIONS AND METHOD
EP3525763B1 (en) 2016-10-12 2025-03-05 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
IL268970B2 (en) 2017-03-24 2023-12-01 Intra Cellular Therapies Inc Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes
CA3071119A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment or prophylaxis of central nervous system disorders
CN111093664B (zh) 2017-07-26 2023-06-02 细胞内治疗公司 有机化合物
WO2019183341A1 (en) 2018-03-23 2019-09-26 Intra-Cellular Therapies, Inc. Organic compounds
EP3801527B1 (en) 2018-06-08 2025-02-19 Intra-Cellular Therapies, Inc. Fused gamma-carbolines for acute treatment of anxiety or depression
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
KR20210052472A (ko) 2018-08-31 2021-05-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CA3108553A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
CN114072150A (zh) 2019-07-07 2022-02-18 细胞内治疗公司 新方法
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
RO111767B1 (ro) * 1990-10-15 1997-01-30 Pfizer Derivati de indol, procedee si intermediari pentru prepararea acestora, compozitii farmaceutice si metoda pentru tratarea unor afectiuni
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 N,n’−ジ置換アミド誘導体
TW226019B (cs) * 1992-03-23 1994-07-01 Sankyo Co

Also Published As

Publication number Publication date
NZ265055A (en) 1996-09-25
BR9406206A (pt) 1996-02-06
EP0694033A1 (en) 1996-01-31
BG100040A (bg) 1996-03-29
AU6538294A (en) 1994-11-08
IT1271352B (it) 1997-05-27
HU9502913D0 (en) 1995-11-28
CN1124960A (zh) 1996-06-19
ITMI930699A1 (it) 1994-10-08
CZ283398B6 (cs) 1998-04-15
FI954734A0 (fi) 1995-10-05
ZA942383B (en) 1995-10-09
WO1994024125A1 (en) 1994-10-27
NO953967L (no) 1995-12-05
CA2160020A1 (en) 1994-10-27
FI954734A7 (fi) 1995-10-05
NO953967D0 (no) 1995-10-05
JPH08508738A (ja) 1996-09-17
SK119795A3 (en) 1996-04-03
ITMI930699A0 (it) 1993-04-08
IL109234A0 (en) 1994-07-31
AU684276B2 (en) 1997-12-11
CZ260295A3 (en) 1996-01-17
FI954734L (fi) 1995-10-05
HUT74090A (en) 1996-11-28
US5834493A (en) 1998-11-10
PL310995A1 (en) 1996-01-22
SG50507A1 (en) 1998-07-20

Similar Documents

Publication Publication Date Title
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
JP3057109B2 (ja) 新規インドール誘導体
JP3834098B2 (ja) ベンゾニトリル類およびベンゾフルオリド類
JP3165181B2 (ja) 新規の3−アリールインドールおよび3−アリールインダゾール誘導体
SK10302001A3 (sk) Piperidínové, tetrahydropyridínové a piperazínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
JP2003524571A (ja) インドール−及び2,3−ジヒドロインドール誘導体、その製造方法及びその使用方法
JPH06271571A (ja) インドール、インダゾール及びベンズイソオキサゾール化合物、それらの製法およびそれらを含有する製薬組成物
AU765317B2 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
DE69819903T2 (de) Bicyclische verbindungen als liganden der 5-ht1 rezeptoren
JP2006502985A (ja) ムスカリン性受容体拮抗剤として有用な3,6−二置換アザビシクロ[3.1.0]ヘキサン誘導体
JPH07500353A (ja) 5−ht1アゴニストとしてのインドール誘導体
HU224703B1 (en) 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-0-tolyl-pyridin-3-yl)-isobutyramide, process for producing it, and pharmaceutical compositions containing it
JP2006522036A (ja) 精神疾患および神経障害の処置のための5−ht受容体アンタゴニスト
ZA200700321B (en) Kynurenic acid amide derivatives as NR2B receptor antagonists
IE63043B1 (en) Cyclic amides
CN100406009C (zh) 作为毒蕈碱受体拮抗剂的取代的氮杂双环己烷衍生物
US6066637A (en) Indolyl derivatives as serotonergic agents
JPS6257606B2 (cs)
EP1073651B1 (en) Indolyl derivatives as serotonergic agents
WO2000049017A1 (en) 1-((indoly azacycloalkyl) alkyl)-2,1, 3-benzothiadiazole 2,2-dioxides exhibiting 5-ht2a receptor activity
JP2002510675A (ja) うつ病治療用のn−アリールオキシエチル−インドリル−アルキルアミン(5−ht1a受容体活性薬)
US6057340A (en) Oxazole derivatives as serotonin-1A receptor agonists
KR101471987B1 (ko) 일정한 cns-관련 질환을 치료하기 위한 2-알킬-인다졸 화합물
US6337336B1 (en) Azaindole derivatives for the treatment of depression
JP3786984B2 (ja) ピペラジン誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void